There’s not a cure-all drug to help us live longer.
Dr. Nir Barzilai, the director of the Institute for Aging Research at the Albert Einstein College of Medicine and board member at The American Federation for Aging Research (AFAR), predicts it will take a few decades to see impactful gerotherapeutics—drugs that counter the aging process—for the average person. The key is discovering safe and effective drugs that target mechanisms, like inflammation and cellular damage, that lead to aging.
